R L Peters1,2, K J Allen1,2,3,4, S C Dharmage1,5, C J Lodge1,5, J J Koplin1,5, A-L Ponsonby1,5, M Wake1,2, A J Lowe1,5, M L K Tang1,2,3, M C Matheson5, L C Gurrin1,5. 1. Murdoch Childrens Research Institute, Parkville, Vic., Australia. 2. Department of Paediatrics, University of Melbourne, Parkville, Vic., Australia. 3. Department of Allergy and Immunology, Royal Children's Hospital, Parkville, Vic., Australia. 4. School of Inflammation and Repair, The University of Manchester, Manchester, UK. 5. Melbourne School of Population and Global Health, Centre for Epidemiology and Biostatistics, University of Melbourne, Parkville, Vic., Australia.
Abstract
BACKGROUND: Food allergy, eczema and wheeze are early manifestations of allergic disease and commonly co-occur in infancy although their interrelationship is not well understood. Data from population studies are essential to determine whether there are differential drivers of multi-allergy phenotypes. We aimed to define phenotypes and risk factors of allergic disease using latent class analysis (LCA). METHODS: The HealthNuts study is a prospective, population-based cohort of 5276 12-month-old infants in Melbourne, Australia. LCA was performed using the following baseline data collected at age 12 months: food sensitization (skin prick test ≥ 2 mm) and allergy (oral food challenge) to egg, peanut and sesame; early (< 4 months) and late-onset eczema; and wheeze in the first year of life. Risk factors were modelled using multinomial logistic regression. RESULTS: Five distinct phenotypes were identified: no allergic disease (70%), non-food-sensitized eczema (16%), single egg allergy (9%), multiple food allergies (predominantly peanut) (3%) and multiple food allergies (predominantly egg) (2%). Compared to the baseline group of no allergic disease, shared risk factors for all allergic phenotypes were parents born overseas (particularly Asia), delayed introduction of egg, male gender (except for single egg allergy) and family history of allergic disease, whilst exposure to pet dogs was protective for all phenotypes. Other factors including filaggrin mutations, vitamin D and the presence of older siblings differed by phenotype. CONCLUSIONS AND CLINICAL RELEVANCE: Multiple outcomes in infancy can be used to determine five distinct allergy phenotypes at the population level, which have both shared and separate risk factors suggesting differential mechanisms of disease.
BACKGROUND:Food allergy, eczema and wheeze are early manifestations of allergic disease and commonly co-occur in infancy although their interrelationship is not well understood. Data from population studies are essential to determine whether there are differential drivers of multi-allergy phenotypes. We aimed to define phenotypes and risk factors of allergic disease using latent class analysis (LCA). METHODS: The HealthNuts study is a prospective, population-based cohort of 5276 12-month-old infants in Melbourne, Australia. LCA was performed using the following baseline data collected at age 12 months: food sensitization (skin prick test ≥ 2 mm) and allergy (oral food challenge) to egg, peanut and sesame; early (< 4 months) and late-onset eczema; and wheeze in the first year of life. Risk factors were modelled using multinomial logistic regression. RESULTS: Five distinct phenotypes were identified: no allergic disease (70%), non-food-sensitized eczema (16%), single egg allergy (9%), multiple food allergies (predominantly peanut) (3%) and multiple food allergies (predominantly egg) (2%). Compared to the baseline group of no allergic disease, shared risk factors for all allergic phenotypes were parents born overseas (particularly Asia), delayed introduction of egg, male gender (except for single egg allergy) and family history of allergic disease, whilst exposure to pet dogs was protective for all phenotypes. Other factors including filaggrin mutations, vitamin D and the presence of older siblings differed by phenotype. CONCLUSIONS AND CLINICAL RELEVANCE: Multiple outcomes in infancy can be used to determine five distinct allergy phenotypes at the population level, which have both shared and separate risk factors suggesting differential mechanisms of disease.
Authors: Alkis Togias; Susan F Cooper; Maria L Acebal; Amal Assa'ad; James R Baker; Lisa A Beck; Julie Block; Carol Byrd-Bredbenner; Edmond S Chan; Lawrence F Eichenfield; David M Fleischer; George J Fuchs; Glenn T Furuta; Matthew J Greenhawt; Ruchi S Gupta; Michele Habich; Stacie M Jones; Kari Keaton; Antonella Muraro; Marshall Plaut; Lanny J Rosenwasser; Daniel Rotrosen; Hugh A Sampson; Lynda C Schneider; Scott H Sicherer; Robert Sidbury; Jonathan Spergel; David R Stukus; Carina Venter; Joshua A Boyce Journal: J Allergy Clin Immunol Date: 2017-01 Impact factor: 10.793
Authors: A R Sitarik; S Havstad; A M Levin; S V Lynch; K E Fujimura; D R Ownby; C C Johnson; G Wegienka Journal: Indoor Air Date: 2018-03-13 Impact factor: 5.770
Authors: Sara Benedé; Ana Belen Blázquez; David Chiang; Leticia Tordesillas; M Cecilia Berin Journal: EBioMedicine Date: 2016-04-16 Impact factor: 8.143
Authors: So Hee Lee; Ga Young Ban; Kyunguk Jeong; Yoo Seob Shin; Hae Sim Park; Sooyoung Lee; Young Min Ye Journal: Allergy Asthma Immunol Res Date: 2017-11 Impact factor: 5.764
Authors: Vladeta Ajdacic-Gross; Margot Mutsch; Stephanie Rodgers; Anja Tesic; Mario Müller; Erich Seifritz; En-Young N Wagner; Roland von Känel; Markus A Landolt; Nina Steinemann; Viktor von Wyl; Enrique Castelao; Marie-Pierre F Strippoli; Jennifer Glaus; Caroline Vandeleur; Pedro M Marques-Vidal; Peter Vollenweider; Martin Preisig Journal: BMC Med Date: 2019-04-09 Impact factor: 8.775